Antibody-drug conjugates (ADCs) represent a groundbreaking advancement in the battle with cancer. ADCs fuse the targeting ability of antibodies with the destructive capability of cytotoxic drugs. By carrying these potent agents directly to malignant tissues , ADCs enhance treatment efficacy while reducing harm to healthy organs. This targeted appro